Review identifies cardioprotective properties and safety of salvianolic acid B in cardiovascular diseases, suggesting further investigation is warranted.
Key Points
The aim is to consolidate research on salvianolic acid B and its potential in treating cardiovascular diseases.
Systematic review of existing research on salvianolic acid B for cardiovascular diseases.
Analysis of pharmacological mechanisms and efficacy characteristics.
Evaluation of safety and compatibility strategies.
Integration of preclinical and clinical data for comprehensive understanding.
Salvianolic acid B exhibits antioxidant and anti-inflammatory properties.
Demonstrates cardioprotective effects through various mechanisms including improved endothelial function.
Evaluated safety indicates it as a promising therapeutic agent for cardiovascular diseases.